Safety profile of the direct oral anticoagulants: an analysis of the WHO database of adverse drug reactions

No abstract is available for this paper.

• Publication year

  2017

• Venue

  British Journal of Clinical Pharmacology

• Publication date

  2017-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/bcp.13234PMID 28071818PMCID PMC5465343
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Safety profile of the direct oral anticoagulants: an analysis of the WHO database of adverse drug reactions

  2017cited by this paper
• NOACs versus warfarin for stroke prevention in patients with AF: a systematic review and meta-analysis

  2016cited by this paper
• Risk of Myocardial Infarction in Patients with Long-Term Non-Vitamin K Antagonist Oral Anticoagulant Treatment.

  2016cited by this paper
• Safety of non-vitamin K antagonist oral anticoagulants - coronary risks

  2016cited by this paper
• Impact of renal function deterioration on adverse events during anticoagulation therapy using non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

  2016cited by this paper
• Anticoagulation in atrial fibrillation and chronic heart failure: the risk and drug of choice

  2016cited by this paper
• Acute Liver Failure after Initiation of Rivaroxaban: A Case Report and Review of the Literature

  2015cited by this paper
• Hepatotoxicity of New Oral Anticoagulants (NOACs)

  2015cited by this paper
• Will NOACs become the new standard of care in anticoagulation therapy

  2015cited by this paper
• Choosing the right drug to fit the patient when selecting oral anticoagulation for stroke prevention in atrial fibrillation

  2015cited by this paper
• Risk of gastrointestinal bleeding associated with oral anticoagulants: population based retrospective cohort study

  2015cited by this paper
• The Concise Guide to PHARMACOLOGY 2015/16: Enzymes

  2015cited by this paper
• [Fatal outcome for a patient in treatment with dabigatran suffering a subtrochanteric femoral fracture].

  2015cited by this paper
• Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH: reply

  2015cited by this paper
• Rivaroxaban-induced liver injury: Results from a venous thromboembolism registry.

  2015cited by this paper
• Rivaroxaban: liver injury.

  2015cited by this paper
• Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study

  2015cited by this paper
• Safety of new oral anticoagulants

  2015cited by this paper
• Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH

  2015cited by this paper
• Liver injury with novel oral anticoagulants: assessing post-marketing reports in the US Food and Drug Administration adverse event reporting system.

  2015cited by this paper
• Safety of the direct-acting anticoagulants in patients with atrial fibrillation: a meta-analysis.

  2015cited by this paper
• Fatal intracerebral bleeding under rivaroxaban.

  2015cited by this paper
• Clinical and Safety Outcomes of Oral Antithrombotics for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Network Meta-analysis.

  2015cited by this paper
• Cardiovascular, Bleeding, and Mortality Risks in Elderly Medicare Patients Treated With Dabigatran or Warfarin for Nonvalvular Atrial Fibrillation

  2015cited by this paper
• The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands

  2015cited by this paper
• A Case of Rivaroxaban Associated Intracranial Hemorrhage

  2014cited by this paper
• Risk of drug-induced liver injury with the new oral anticoagulants: systematic review and meta-analysis

  2014cited by this paper
• Dabigatran Etexilate and Risk of Myocardial Infarction, Other Cardiovascular Events, Major Bleeding, and All‐Cause Mortality: A Systematic Review and Meta‐analysis of Randomized Controlled Trials

  2014cited by this paper
• Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients

  2014cited by this paper
• NOAC and intracerebral bleeding--presentation of four cases and review of the literature.

  2014cited by this paper
• Rıvaroxaban-induced severe diffuse ıntracerebral hemorrhage.

  2014cited by this paper
• Symptomatic hepatocellular liver injury with hyperbilirubinemia in two patients treated with rivaroxaban.

  2014cited by this paper
• Secondary hematoma expansion in intracerebral hemorrhage during rivaroxaban therapy.

  2014cited by this paper
• Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.

  2014cited by this paper
• Underreporting in pharmacovigilance: an intervention for Italian GPs (Emilia–Romagna region)

  2013cited by this paper
• Meta-analysis of randomized controlled trials on risk of myocardial infarction from the use of oral direct thrombin inhibitors.

  2013cited by this paper
• New oral anticoagulants increase risk for gastrointestinal bleeding: a systematic review and meta-analysis.

  2013cited by this paper
• New oral anticoagulants and the risk of intracranial hemorrhage: traditional and Bayesian meta-analysis and mixed treatment comparison of randomized trials of new oral anticoagulants in atrial fibrillation.

  2013cited by this paper
• Dabigatran association with higher risk of acute coronary events: meta-analysis of noninferiority randomized controlled trials.

  2012cited by this paper
• Apixaban versus Warfarin in Patients with Atrial Fibrillation

  2012cited by this paper
• Myocardial Ischemic Events in Patients With Atrial Fibrillation Treated With Dabigatran or Warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial

  2012cited by this paper
• Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

  2011cited by this paper
• Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

  2011cited by this paper
• Apixaban versus warfarin in patients with atrial fibrillation.

  2011cited by this paper
• The effect of a new direct Factor Xa inhibitor on human osteoblasts: an in-vitro study comparing the effect of rivaroxaban with enoxaparin

  2011cited by this paper
• Dabigatran versus warfarin in patients with atrial fibrillation.

  2009cited by this paper
• Quantitative signal detection using spontaneous ADR reporting

  2009cited by this paper
• Influence of Regulatory Measures on the Rate of Spontaneous Adverse Drug Reaction Reporting in Italy

  2008cited by this paper
• Pharmacovigilance in the 21st Century: New Systematic Tools for an Old Problem

  2004cited by this paper

• Post-marketing safety profile of dengue vaccines CYD-TDV and TAK-003: analysis of adverse event reports from a European database.

  2026cites this paper
• When Atrial Fibrillation Meets Alcoholic Liver Cirrhosis: Can Direct Oral Anticoagulants Bridge the Therapeutic Gap?

  2026cites this paper
• Vitamin K Antagonists (VKAs) and Novel Oral Anticoagulants (NOACs) Safety Comparison Based on Data from EudraVigilance Database

  2025cites this paper
• The importance of intensive follow-up and achieving optimal chronic antithrombotic treatment in hospitalized medical patients with anemia: a prospective cohort study.

  2024cites this paper
• Safety of Inclisiran: A Disproportionality Analysis from the EudraVigilance Database

  2024cites this paper
• Risks of oral anticoagulants: Analysis of adverse drug reactions reported to the Portuguese National Pharmacovigilance System

  2024influential citation
• Drug-related problems associated with direct oral anticoagulants: an observational cross-sectional study of medical record review by pharmacists in a large teaching hospital

  2024cites this paper
• Could direct oral anticoagulants induce non-hemorrhagic joint disorders?

  2023cites this paper
• Retrospective analysis of gastrointestinal bleedings with direct oral anticoagulants reported to EudraVigilance

  2023cites this paper
• Cutaneous Ulcer Caused by Apixaban Treatment Is Resolved after Replacement with Dabigatran

  2022cites this paper
• Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: An analysis from the Italian pharmacovigilance database

  2022cites this paper
• Use of SAMe-TT_2R_2 in a racially diverse anticoagulation clinic: prediction of optimal anticoagulation

  2022cites this paper
• Thromboembolic Events While Taking Direct Oral Anticoagulants: An Analysis of Post-market WHO Database Reports from 2012 to 2020

  2022cites this paper
• Five Years of Direct Oral Anticoagulants Use in Italy: Adverse Drug Reactions from the Italian National Pharmacovigilance Network

  2022cites this paper
• Relationship Amongst Vitamin K Status, Vitamin K Antagonist Use and Osteoarthritis: A Review

  2022influential citation
• Vascular Brain Damage in Thalassemia Syndrome: An Emerging Challenge

  2022cites this paper
• Comparative study of adverse drug reactions among direct-acting oral anticoagulants and vitamin K antagonists using the EudraVigilance database

  2021cites this paper
• Adverse drug reactions with oral anticoagulants: data from sicilian spontaneous reporting system database

  2021influential citation
• Drug-Drug Interactions Leading to Adverse Drug Reactions with Rivaroxaban: A Systematic Review of the Literature and Analysis of VigiBase

  2021cites this paper
• Risk of Bleeding Associated with Antidepressant Drugs: The Competitive Impact of Antithrombotics in Quantitative Signal Detection

  2021cites this paper
• Enoxaparin versus Direct Oral Anticoagulants for Venous Thromboemoblism in Asians Undergoing Total Knee Arthroplasty: A Meta-Analysis and Systematic Review.

  2021cites this paper
• Association of Direct Oral Anticoagulants (DOACs) and Warfarin With Haemorrhagic Risk by Applying Correspondence Analysis to Data From the Italian Pharmacovigilance Database – A Case Study

  2021cites this paper
• Drug-induced disseminated intravascular coagulation: a pharmacovigilance study on World Health Organization’s database

  2020cites this paper
• Spontaneous reports of adverse drug reactions related to oral anticoagulants in the Czech Republic

  2020cites this paper
• Comparison of Three Different Data Sources of Adverse Drug Reactions Using Adverse Drug Reaction Data of Fluorouracil for Gastric Cancer as an Example.

  2020cites this paper
• Twice- or Once-Daily Dosing of Direct Oral Anticoagulants, a systematic review and meta-analysis.

  2020cites this paper
• Predictors of hemorrhagic stroke in older persons taking nonsteroidal anti-inflammatory drugs: Results from the Food and Drug Administration Adverse Event Reporting System

  2020cites this paper
• Drug interactions with apixaban: A systematic review of the literature and an analysis of VigiBase, the World Health Organization database of spontaneous safety reports

  2020cites this paper
• Relevance of physicochemical properties and functional pharmacology data to predict the clinical safety profile of direct oral anticoagulants

  2020cites this paper
• Spotlight Commentary: A post approval look at anticoagulants.

  2019cites this paper
• Preventable Cases of Oral Anticoagulant-Induced Bleeding: Data From the Spontaneous Reporting System

  2019cites this paper
• The risk of delayed intracranial hemorrhage with direct acting oral anticoagulants after trauma: A two-center study.

  2019cites this paper
• Comparison of Safety Profiles of New Oral Anticoagulants with Warfarin Using the Japanese Spontaneous Reporting Database

  2019cites this paper
• Anticoagulants oraux directs

  2018cites this paper
• Patented medicines that have clinical benefits but did not meet the EML Expert Review committee ’ s comparative cost-effectiveness criterion : Case study on novel oral anticoagulants 5

  2018cites this paper
• Stroke Prevention in Patients With Atrial Fibrillation: A Systematic Review Update

  2018cites this paper
• Need of the Hour: Warfarin-induced Massive Intraperitoneal Bleed

  2018cites this paper
• Use of oral anticoagulants in German nursing home residents: drug use patterns and predictors for treatment choice

  2018cites this paper
• Oral Anticoagulants in German nursing home residents – Drug use patterns and predictors for treatment choice Running head : Oral Anticoagulants in German nursing homes

  2017cites this paper
• Safety profile of the direct oral anticoagulants: an analysis of the WHO database of adverse drug reactions

  2017cites this paper
• [Misuse and adverse effects of new direct oral anticoagulants: A prospective observational study in patients admitted to an emergency unit of a French university hospital].

  2017cites this paper
• Rivaroxaban in patients with atrial fibrillation: from ROCKET AF to everyday practice

  2017cites this paper
• Anticoagulation in atrial fibrillation and chronic heart failure: the risk and drug of choice

  2016cites this paper